IntelliPharmaCeutics International (IPCI)
Add to Watchlists Create an Alert
1.809
-0.03 -1.70%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
IntelliPharmaCeutics International Cash from Financing Quarterly:
1.478M for Feb. 28, 2013IntelliPharmaCeutics International Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Feb. 28, 2013 | 1.478M |
| Nov. 30, 2012 | -0.0541M |
| Aug. 31, 2012 | -0.1129M |
| May 31, 2012 | 4.479M |
| Feb. 29, 2012 | 0.0519M |
| Nov. 30, 2011 | -0.4576M |
| Aug. 31, 2011 | -0.0029M |
| May 31, 2011 | -0.0043M |
| Feb. 28, 2011 | 11.73M |
| Nov. 30, 2010 | -0.0194M |
| Aug. 31, 2010 | -0.0096M |
| May 31, 2010 | -0.1139M |
| Feb. 28, 2010 | -0.7641M |
| Nov. 30, 2009 | 0.7985M |
| Aug. 31, 2009 | 0.00 |
| May 31, 2009 | 0.00 |
| Feb. 28, 2009 | 0.00 |
| Nov. 30, 2008 | 0.00 |
| Aug. 31, 2008 | 0.00 |
| May 31, 2008 | 0.00 |
| Feb. 29, 2008 | Go Pro |
| Nov. 30, 2007 | Go Pro |
| Aug. 31, 2007 | Go Pro |
| May 31, 2007 | Go Pro |
| Feb. 28, 2007 | Go Pro |
| Nov. 30, 2006 | Go Pro |
| Aug. 31, 2006 | Go Pro |
| May 31, 2006 | Go Pro |
| Feb. 28, 2006 | Go Pro |
| Nov. 30, 2005 | Go Pro |
| Aug. 31, 2005 | Go Pro |
| May 31, 2005 | Go Pro |
| Feb. 28, 2005 | Go Pro |
| Nov. 30, 2004 | Go Pro |
| Aug. 31, 2004 | Go Pro |
| May 31, 2004 | Go Pro |
| Feb. 29, 2004 | Go Pro |
| Nov. 30, 2003 | Go Pro |
| Aug. 31, 2003 | Go Pro |
| May 31, 2003 | Go Pro |
| Feb. 28, 2003 | Go Pro |
| Nov. 30, 2002 | Go Pro |
| Aug. 31, 2002 | Go Pro |
| May 31, 2002 | Go Pro |
| Feb. 28, 2002 | Go Pro |
| Nov. 30, 2001 | Go Pro |
| Aug. 31, 2001 | Go Pro |
| May 31, 2001 | Go Pro |
| Feb. 28, 2001 | Go Pro |
| Nov. 30, 2000 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
IPCI Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Celgene Corporation | -687.40M |
| Elan | 13.60M |
| ARCA biopharma | 1.39M |
IPCI Cash from Financing Quarterly Rankings
| Overall |
84th percentile 1251 of 8009 |
| Sector |
74th percentile 173 of 687 in Healthcare |
| Industry |
70th percentile 74 of 248 in Biotechnology |
IPCI Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -0.7641M | Feb 2010 |
| Maximum | 11.73M | Feb 2011 |
| Average | 0.8501M |